Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

Targeting PI3K in female cancers

Dr Lewis Cantley - Weill Cornell Medical College, New York, USA
Targeting PI3K in female cancers ( Dr Lewis Cantley - Weill Cornell Medical College, New York, USA )
10 Nov 2014

Research shows chemotherapy has no negative effects on babies in utero

Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium
Research shows chemotherapy has no negative effects on babies in utero ( Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium )
1 Oct 2014

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain
Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer ( Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain )
1 Oct 2014

Cediranib and chemo combo improves PFS for metastatic cervical cancer

Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK
Cediranib and chemo combo improves PFS for metastatic cervical cancer ( Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Dr Paul Symonds - University Hospital of Leicester, Leicester, UK
Adding cediranib to chemo improves PFS for metastatic cervical cancer ( Dr Paul Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014

ecancermedicalscience editor's choice for July and August 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for July and August 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Aug 2014

Networking and collaborating across borders in sub-Saharan Africa

Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh -  Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014

Molecular investigations of immune cells and tumour environment: The ovarian cancer model

Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland
Molecular investigations of immune cells and tumour environment: The ovarian cancer model ( Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland )
26 Jun 2014

HPV-targeted adoptive T Cell therapy for advanced cervical cancer

Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA
HPV-targeted adoptive T Cell therapy for advanced cervical cancer ( Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA )
2 Jun 2014

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )
2 Jun 2014